AGP Executive Report
Last update: 9 hours agoMedicines Access & Pricing: Greece backs deeper EU cooperation on medicines procurement and supply security, with health ministers set to discuss more coordinated approaches to pharmaceutical pricing and procurement in Luxembourg on 16 June. Hospital Outpatient Reform: Luxembourg’s planned outpatient structures linked to hospitals are drawing concern from hospital doctors, who want clearer rules on how new doctor associations differ from satellite centres and how agreements would work in practice. EU Court Transparency on Covid Vaccines: An EU court adviser recommends dismissing the Commission’s appeal in a Luxembourg-linked case over public access to details of Covid-19 vaccine contract negotiations, keeping transparency and public trust in the spotlight. Drug Use Trends in Luxembourg: Luxembourg’s national drug report says cannabis remains the most used drug (nearly 15% of adults in the past year), with rising cocaine and opioid consumption down; wastewater monitoring shows widespread availability and increasing cannabis potency. Public Health Risks for Travellers: UK health authorities report 164 dysentery (Shigella) and Salmonella cases linked to Cape Verde travel, urging extra caution as clusters have been detected across multiple European countries. Heart Screening Tech: HeartSciences announces a European Patent Office grant for ECG-based assessment of diastolic function, aiming to turn ECG into a more valuable front-line screening tool. Cold-Chain Pharma Logistics: DSV expands its Luxembourg–Indianapolis Air ThermoDirect corridor for temperature-sensitive medicines, warning the industry may be unprepared for newer personalised therapies needing different handling.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.